Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy*

References

• Terzi C, Arslan NC, Canda AE. (2014). Peritoneal carcinomatosis of gastrointestinal tumours: where are we now? World J Gastroenterol 20:14371–80.
   PubMed Web of Science ®Google Scholar
• Klaver YL, Simkens LH, Lemmens VE, et al. (2012). Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol 38:617–23.
   PubMed Web of Science ®Google Scholar
• Esquivel J, Sticca R, Sugarbaker P, et al. (2007). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Soc Surg Oncol. Ann Surg Oncol 14:128–33.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Sugarbaker PH. (1996). Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–74.
   PubMedGoogle Scholar
• Pelz JO, Chua TC, Esquivel J, et al. (2010). Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer 10:689.
   PubMed Web of Science ®Google Scholar
• Cashin PH, Graf W, Nygren P, Mahteme H. (2012). Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumour markers: an observational cohort study. Ann Surg 256:1078–83.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FA. (2004). Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 91:739–46.
   PubMed Web of Science ®Google Scholar
• Aguiar S Jr. (2010). Peritoneal carcinomatosis from colorectal cancer: the need for improving selection criteria for cytoreductive surgery and intraperitoneal chemotherapy. J Surg Oncol 102:563–4.
   PubMed Web of Science ®Google Scholar
• Yan TD, Sim J, Morris DL. (2007). Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 14:1807–17.
   PubMed Web of Science ®Google Scholar
• Cotte E, Passot G, Gilly F-N, Glehen O. (2010). Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2:31–5.
   PubMedGoogle Scholar
• Sheehe P. (1966). Combination of log relative risk in retrospective studies of disease. Am J Public Health Nations Heath 56:1745–50.
   PubMed Web of Science ®Google Scholar
• Portilla AG, Shigeki K, Dario B, Marcello D. (2008). The intraoperative staging systems in the management of peritoneal surface malignancy. J Surg Oncol 98:228–31.
   PubMed Web of Science ®Google Scholar
• Esquivel J, Chua TC, Stojadinovic A, et al. (2010). Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol 102:565–70.
   PubMed Web of Science ®Google Scholar
• Pomel C, Appleyard TL, Gouy S, et al. (2005). The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 31:540–3.
   PubMed Web of Science ®Google Scholar
• Riss S, Mohamed F, Dayal S, et al. (2013). Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 39:931–7.
   PubMed Web of Science ®Google Scholar
• Jayakrishnan TT, Zacharias AJ, Sharma A, et al. (2014). Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol 21:270.
   Web of Science ®Google Scholar
• Yan TD, Morris DL, Shigeki K, et al. (2008). Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: expert consensus statement. J Surg Oncol 98:224–7.
   PubMed Web of Science ®Google Scholar
• Cashin PH, Graf W, Nygren P, Mahteme H. (2013). Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 20:4183–9.
   PubMed Web of Science ®Google Scholar
• Nakamoto H. (2005). Encapsulating peritoneal sclerosis – a clinician’s approach to diagnosis and medical treatment. Perit Dial Int 25:S30–8.
   PubMed Web of Science ®Google Scholar
• Caldwell J, Dyer A. (2013). Sclerosing encapsulating peritonitis (cocoon bowel) presenting after laparotomy for splenic abscess. J Radiol Case Rep 7:17–23.
   PubMedGoogle Scholar
• Goldstein DP. (2007). Surgical strategies to untangle a frozen pelvis. OBG Manag 19:65–70.
   Google Scholar
• Hsu AL, Khachikyan I, Stratton P. (2010). Invasive and non-invasive methods for the diagnosis of endometriosis. Clin Obstet Gynecol 53:413–19.
   PubMed Web of Science ®Google Scholar
• Sugarbaker P. (1995). Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 19:235–40.
   PubMed Web of Science ®Google Scholar
• Passot G, Vaudoyer D, Cotte E, et al. (2012). Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis. Ann Surg 256:125–9.
   PubMed Web of Science ®Google Scholar
• Turner KM, Hanna NN, Zhu Y, et al. (2013). Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer. Ann Surg Oncol 20:1068–73.
   PubMed Web of Science ®Google Scholar
• Ceelen W, Van Nieuwenhove Y, Putte DV, Pattyn P. (2014). Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis. Ann Surg Oncol 21:3023–8.
   PubMed Web of Science ®Google Scholar
• Passot G, You B, Boschetti G, et al. (2014). Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. Ann Surg Oncol 21:2608–14.
   PubMed Web of Science ®Google Scholar
• Woodward P, Hosseinzadeh K, Saenger J. (2004). From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics 24:225–46.
   PubMed Web of Science ®Google Scholar
• O'Neill AC, Shinagare AB, Rosenthal MH, et al. (2014). Differences in CT features of peritoneal carcinomatosis, sarcomatosis, and lymphomatosis: retrospective analysis of 122 cases at a tertiary cancer institution. Clin Radiol 69:1219–27.
   PubMed Web of Science ®Google Scholar
• O’Connell JB, Maggard MA, Liu JH, et al. (2004). Do young colon cancer patients have worse outcomes? World J Surg 28:558–62.
   PubMed Web of Science ®Google Scholar